{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:50:01Z","timestamp":1792090201778,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"DOI":"10.1007\/s12282-026-01926-4","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:03:04Z","timestamp":1792087384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time toxicity in breast cancer care: a nationwide cross-sectional survey of multidimensional time burden in Japan"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3643-9862","authenticated-orcid":false,"given":"Hitomi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Tsukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yodogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Arata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukushi","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Oshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"1926_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1200\/OP.21.00662","volume":"18","author":"A Gupta","year":"2022","unstructured":"Gupta A, Jensen EH, Virnig BA, Beg MS. Time-related burdens of cancer care. JCO Oncol Pract. 2022;18:245\u20136. https:\/\/doi.org\/10.1200\/OP.21.00662.","journal-title":"JCO Oncol Pract"},{"key":"1926_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318:197\u20138. https:\/\/doi.org\/10.1001\/jama.2017.7156.","journal-title":"JAMA"},{"key":"1926_CR3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","volume":"10","author":"C Quinten","year":"2009","unstructured":"Quinten C, Coens C, Mauer M, Comte S, Sprangers MAG, Cleeland C, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009;10:865\u201371. https:\/\/doi.org\/10.1016\/S1470-2045(09)70200-1.","journal-title":"Lancet Oncol"},{"key":"1926_CR4","doi-asserted-by":"publisher","first-page":"8423","DOI":"10.1002\/cam4.3461","volume":"9","author":"GB Rocque","year":"2020","unstructured":"Rocque GB, Williams CP, Ingram SA, Azuero A, Mennemeyer ST, Young Pierce J, et al. Health care-related time costs in patients with metastatic breast cancer. Cancer Med. 2020;9:8423\u201331. https:\/\/doi.org\/10.1002\/cam4.3461.","journal-title":"Cancer Med"},{"key":"1926_CR5","first-page":"393","volume":"20","author":"C Bleustein","year":"2014","unstructured":"Bleustein C, Rothschild DB, Valen A, Valatis E, Schweitzer L, Jones R. Wait times, patient satisfaction scores, and the perception of care. Am J Manag Care. 2014;20:393\u2013400.","journal-title":"Am J Manag Care"},{"key":"1926_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-68","volume":"10","author":"V-T Tran","year":"2012","unstructured":"Tran V-T, Montori VM, Eton DT, Baruch D, Falissard B, Ravaud P. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med. 2012;10:68. https:\/\/doi.org\/10.1186\/1741-7015-10-68.","journal-title":"BMC Med"},{"key":"1926_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-281","volume":"14","author":"CR May","year":"2014","unstructured":"May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, MacDonald S, et al. Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness. BMC Health Serv Res. 2014;14:281. https:\/\/doi.org\/10.1186\/1472-6963-14-281.","journal-title":"BMC Health Serv Res"},{"key":"1926_CR8","unstructured":"Zafar SY, Abernethy AP. Financial toxicity, Part II: how can we help with the burden of treatment-related costs? Oncology (Williston Park). Williston Park, N.Y. 2013;27:253\u2013254, 256."},{"key":"1926_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","volume":"34","author":"KR Yabroff","year":"2016","unstructured":"Yabroff KR, Dowling EC, Guy GP, Banegas MP, Davidoff A, Han X, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34:259\u201367. https:\/\/doi.org\/10.1200\/JCO.2015.62.0468.","journal-title":"J Clin Oncol"},{"key":"1926_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3322\/caac.21443","volume":"68","author":"PM Carrera","year":"2018","unstructured":"Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin. 2018;68:153\u201365. https:\/\/doi.org\/10.3322\/caac.21443.","journal-title":"CA Cancer J Clin"},{"key":"1926_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/PROM.S78955","volume":"6","author":"DT Eton","year":"2015","unstructured":"Eton DT, Ridgeway JL, Egginton JS, Tiedje K, Linzer M, Boehm DH, et al. Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions. Patient Relat Outcome Meas. 2015;6:117\u201326. https:\/\/doi.org\/10.2147\/PROM.S78955.","journal-title":"Patient Relat Outcome Meas"},{"key":"1926_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.7326\/M16-0961","volume":"165","author":"C Sinsky","year":"2016","unstructured":"Sinsky C, Colligan L, Li L, Prgomet M, Reynolds S, Goeders L, et al. Allocation of physician time in ambulatory practice: a time and motion study in 4 specialties. Ann Intern Med. 2016;165:753\u201360. https:\/\/doi.org\/10.7326\/M16-0961.","journal-title":"Ann Intern Med"},{"key":"1926_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3322\/caac.20081","volume":"60","author":"LL Northouse","year":"2010","unstructured":"Northouse LL, Katapodi MC, Song L, Zhang L, Mood DW. Interventions with family caregivers of cancer patients: meta-analysis of randomized trials. CA Cancer J Clin. 2010;60:317\u201339. https:\/\/doi.org\/10.3322\/caac.20081.","journal-title":"CA Cancer J Clin"},{"key":"1926_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1926_CR15","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1200\/JCO.2015.61.6706","volume":"33","author":"LE Schnipper","year":"2015","unstructured":"Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, et al. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol. 2015;33:2563\u201377. https:\/\/doi.org\/10.1200\/JCO.2015.61.6706.","journal-title":"J Clin Oncol"},{"key":"1926_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.18553\/jmcp.2017.23.2.136","volume":"23","author":"KM Kamal","year":"2017","unstructured":"Kamal KM, Covvey JR, Dashputre A, Ghosh S, Shah S, Bhosle M, et al. A systematic review of the effect of cancer treatment on work productivity of patients and caregivers. J Manag Care Spec Pharm. 2017;23:136\u201362. https:\/\/doi.org\/10.18553\/jmcp.2017.23.2.136.","journal-title":"J Manag Care Spec Pharm"},{"key":"1926_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1136\/bmj.320.7251.1713","volume":"320","author":"G Eysenbach","year":"2000","unstructured":"Eysenbach G. Consumer health informatics. BMJ Clin Res Ed. 2000;320:1713\u20136. https:\/\/doi.org\/10.1136\/bmj.320.7251.1713.","journal-title":"BMJ Clin Res Ed"},{"key":"1926_CR18","doi-asserted-by":"publisher","first-page":"e2447649","DOI":"10.1001\/jamanetworkopen.2024.47649","volume":"7","author":"A Gupta","year":"2024","unstructured":"Gupta A, Johnson WV, Henderson NL, Ogunleye OO, Sekar P, George M, et al. Patient, caregiver, and clinician perspectives on the time burdens of cancer care. JAMA Netw Open. 2024;7:e2447649. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.47649.","journal-title":"JAMA Netw Open"},{"key":"1926_CR19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.annonc.2025.04.006","volume":"36","author":"NI Cherny","year":"2025","unstructured":"Cherny NI, Oosting SF, Dafni U, Latino NJ, Galotti M, Zygoura P, et al. ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0). Ann Oncol. 2025;36:866\u2013908. https:\/\/doi.org\/10.1016\/j.annonc.2025.04.006.","journal-title":"Ann Oncol"},{"key":"1926_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/s0277-9536(96)00221-3","volume":"44","author":"C Charles","year":"1997","unstructured":"Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44:681\u201392. https:\/\/doi.org\/10.1016\/s0277-9536(96)00221-3.","journal-title":"Soc Sci Med"},{"key":"1926_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-023-02263-8","volume":"23","author":"N Oprea","year":"2023","unstructured":"Oprea N, Ardito V, Ciani O. Implementing shared decision-making interventions in breast cancer clinical practice: a scoping review. BMC Med Inform Decis Mak. 2023;23:164. https:\/\/doi.org\/10.1186\/s12911-023-02263-8.","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01926-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:03:05Z","timestamp":1792087385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01926-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":21,"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01926-4","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Hitomi Suzuki has received honoraria for lectures from Chugai Pharmaceutical, Kyowa Kirin, Daiichi Sankyo, Eli Lilly, MSD, Pfizer, and Exact Sciences, and advisory board fees from Daiichi Sankyo. The remaining authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}